At QueenRX, the most consequential step may come before a package ships: understanding who takes responsibility after checkout. The website markets a relatively simple journey—choose a plan, complete a questionnaire and receive clinical review—but its terms divide the work among a technology company, an affiliated medical practice and a pharmacy network. For someone considering treatment, those distinctions determine whom to contact about a prescription, a delayed shipment, a refund or an unanswered clinical question.
This review follows that care-delivery chain using public documentation consulted October 19, 2026. QueenRX documents access to compounded semaglutide and tirzepatide, not merely a general wellness service. It also presents conflicting availability notices and prices that cannot reliably be assigned to individual packages. The useful question is therefore not just what QueenRX advertises, but which parts of the transaction are documented clearly enough to understand before paying—and which still require a direct answer.
At a glance
- Platform and clinical responsibility
- Mini Labs, LLC operates QueenRX. Its terms say QueenRX does not provide medical services and list Beluga Health PC as a provider group.Sources: [3]
- Documented treatment packages
- The catalog lists three-month starter and maintenance packages for compounded semaglutide and tirzepatide, with consultation, prescription if appropriate, medication and injection supplies advertised as included.
- Pricing needs reconciliation
- The homepage advertises quarterly compounded GLP-1 treatment at $299 without identifying the molecule; the product page displays $699 and $299 under “First month.” Neither establishes a clear price for every package.
- Geographic restrictions
- The service is limited to people located in the United States and states where it lawfully operates; the terms explicitly exclude residents of Alabama, Louisiana and North Carolina.Sources: [3]
- Cancellation boundary
- The refund policy permits cancellation for a refund before the doctor finalizes the prescription and the pharmacy begins processing. Once processing starts, cancellation is unavailable.Sources: [4]
Start with the people behind the platform
QueenRX is the consumer-facing name, but Mini Labs, LLC is the operator identified in its terms. Those terms expressly say QueenRX does not provide medical services; it supplies technology for access to a healthcare provider employed by or contracted with a partner physician practice. Elsewhere, the site describes affiliated practices as independently owned and operated by licensed physicians. These are the provider’s representations, not independently verified licensing findings.
The terms name Beluga Health PC, with an address in Dover, Delaware, under provider groups and Foothills Pharmacy, in Tempe, Arizona, under pharmacies. Naming those organizations helps establish the intended chain of responsibility. It does not establish which individual clinician will review an application or which pharmacy will fill every order. Patients should distinguish the platform from the clinical practice rather than treating all messages bearing the QueenRX name as coming from one care team.
That distinction becomes practical when something needs attention. A commercial billing question is different from a question about a prescription or dispensing instructions. QueenRX publishes customer-support and records-request email addresses, but the consulted documentation does not give a complete escalation map connecting the platform, prescribing practice and dispensing pharmacy. Before paying, obtaining the responsible practice’s contact route and the eventual pharmacy’s contact information would make the advertised service easier to navigate.
Establish whether intake is actually open
The first operational uncertainty is whether QueenRX is accepting new orders. Its treatment page says the product is in stock and ships in three to seven business days if the applicant is eligible. The same page also announces a temporary pause in new-customer orders while existing prescriptions are processed, with orders resuming June 7. No year accompanies that date. These statements cannot establish present availability, and a functioning checkout would not resolve the contradiction by itself.
Geography also needs confirmation before enrollment. The terms limit use to people located in the United States, require location in a state where the relevant service lawfully operates and explicitly exclude residents of Alabama, Louisiana and North Carolina. That is not a complete, medication-specific service map. An address for a provider group or pharmacy does not mean QueenRX serves every other state, nor does it establish that someone traveling outside their home state can receive care.
The intake asks whether the applicant is over 18. The terms describe an 18-or-over requirement, contain a parental-consent clause for access contrary to that requirement and say some services may be limited to people over 21. This is not a clear promise of pediatric treatment or a uniform age rule for every offering. Adults close to those thresholds should ask which requirement applies to the specific package rather than relying on the general language.
What happens between the questionnaire and a prescription
QueenRX’s advertised sequence is to choose a plan, check out and complete a questionnaire, followed by a doctor within 48 hours to confirm a prescription if eligible. The product page separately advertises a same-day initial consultation. These may describe different stages, but the documentation does not reconcile them. The terms allow audio, video and asynchronous communication, including secure messages and email; they do not establish that every applicant receives a live video appointment.
The visible questionnaire asks for location, height, weight and pregnancy or breastfeeding status. It also collects histories involving gastrointestinal, pancreatic, gallbladder, cardiovascular, kidney, metabolic and thyroid conditions, eating disorders, recent suicidal thoughts and GLP-1 hypersensitivity. Those questions show that intake goes beyond selecting a product. They do not, by themselves, identify automatic exclusions or confirm how a clinician investigates an affirmative answer. No complete laboratory protocol or provider-specific BMI threshold is documented.
The product selector distinguishes starter from maintenance packages. The semaglutide starter description addresses people new to GLP-1 treatment, those who have not used it in the previous two months or those wishing to restart from the beginning. The maintenance listing requires a label or prescription photo showing name, date and dosage. These are enrollment descriptions, not instructions to restart or change treatment. A useful first-consultation preparation list should support clinician review rather than substitute for it.
Resolve the package and payment before authorizing care
QueenRX lists four packages: starter and maintenance versions for semaglutide and tirzepatide. The purchase block includes a virtual doctor consultation and access, a prescription if appropriate, three months of medication, syringes and alcohol pads. Other descriptions use 12 weeks instead of three months. Those durations are not interchangeable, and neither alone establishes vial count, concentration or dispensing schedule. The supplies suggest an injectable presentation, but the purchase block does not specify the anatomical administration route.
Pricing is less settled than the package names. The homepage advertises quarterly compounded GLP-1 treatment for $299 without identifying the molecule or package. The product page displays $699 and $299 beneath “First month” before the selector. The pages do not support converting either figure into a definitive monthly or quarterly charge for all four options. A written checkout summary should identify the medication, formulation, presentation, covered period, total collected and any shipping or taxes.
The service is cash-pay: QueenRX and affiliated practices say they do not accept commercial insurance and are not enrolled in Medicare or Medicaid. The terms also say there is no obligation to provide healthcare or pharmacy services until full payment is received or verified. Services outside the platform’s offered arrangements may cost extra. Although the package is advertised as a one-time purchase without membership fees, general subscription clauses remain in the terms; they do not establish that this package automatically renews.
| Item | Public documentation | Clarify before payment |
|---|---|---|
| Package options | Semaglutide and tirzepatide, each with starter and maintenance listings | Which exact package is available and clinically considered |
| Treatment period | Both three months and 12 weeks appear | Exact covered dates, quantity and dispensing schedule |
| Included items | Consultation/access, prescription if appropriate, medication, syringes and alcohol pads | Follow-up scope and any services charged separately |
| Price display | $299 quarterly on the homepage; $699 and $299 under “First month” on the product page | Final package-specific charge, shipping and taxes |
| Payment structure | One-time purchase advertised; general terms also discuss subscriptions | Whether this transaction has any recurring authorization |
The prescription-to-pharmacy handoff
QueenRX says medications are compounded for an individual patient based on a licensed provider’s prescription and clinical assessment. Its terms name Foothills Pharmacy but also refer to a pharmacy network, so the named pharmacy should not be assumed to fill every order. The terms allow selection of a partner pharmacy and allow a pharmacy of the patient’s choice when that option is presented during use of the service. That qualification matters: unrestricted transfer is not promised.
The full formulation of each preparation is not clearly documented. Ingredient names alone do not establish concentration, additives, presentation or route, and promotional comparisons with brand-name medicines do not establish equivalence. FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. FDA recommends their use when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
Nonapproval alone does not demonstrate clinical inequivalence, but it makes product-specific information important. The pharmacy-handoff questions should include who is dispensing, what exactly is prescribed and who explains the label and measuring instructions. FDA has received reports of measurement and administration errors with compounded medication, including some associated with hospitalization. QueenRX’s documentation does not justify attributing those reports to this provider; they explain why clear instructions from the prescriber or pharmacist matter.
Shipping has more than one clock
QueenRX says shipments travel by UPS from its pharmacy or network compounding pharmacies. Its three-to-seven-business-day statement concerns shipping if eligible, not guaranteed arrival at the home. Clinical review, pharmacy processing, dispatch and transit are separate stages. Neither the same-day consultation claim nor the 48-hour doctor-follow-up claim establishes a delivery date. The order-pause notice adds a further unresolved question about whether any advertised dispatch window currently applies.
The consulted documentation does not explain refrigerated packaging, transport temperature controls or how a temperature excursion is assessed. That absence is not proof that appropriate packaging is never used. It means a prospective patient lacks a documented handling plan. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That advice is more specific than simply reporting that a shipment was late.
There are two other practical delivery conditions. The terms warn that medication supplied through the QueenRX network will not arrive in child-resistant packaging and must be kept out of children’s reach. The refund policy asks customers to report verified shipping damage or dispensing errors within 48 hours of receipt, providing an order number, tracking number and photographs when applicable. Keeping those records supports the reporting process, but the policy does not promise an automatic refund for every complaint.
Ongoing access is not a documented follow-up schedule
The homepage advertises around-the-clock doctor access for discussing treatment and concerns. The product page promises ongoing care and check-ins. Those are meaningful service claims, but the documentation does not establish visit frequency, a response-time commitment, the channel used for clinical questions or the boundaries of included access. Availability language should not be read as a guarantee of an immediate consultation. It also leaves unclear how care continues once the initial package period ends.
NIDDK describes follow-up as attention to treatment response and tolerability, not simply continued purchasing. Against that standard, a useful question for QueenRX is who initiates check-ins and what happens if a patient reports a problem between them. Its three-month marketing does not establish the appropriate treatment duration for any individual. A discussion of what ongoing support includes should separate scheduled clinical review, messages, customer service and the administrative process for another purchase.
Continuity and privacy also intersect here. Patients can request transfer of their telehealth record by emailing team@joinqueenrx.com with consent and the receiving professional’s name, address and phone number. The terms warn that texts and emails are not encrypted. The privacy policy also permits certain advertising disclosures, potentially including sensitive health data that it does not classify as protected health information. These provisions warrant attention without assuming that every clinical record is shared with advertisers.
Know when the transaction becomes difficult to unwind
QueenRX’s refund policy draws an operational boundary rather than a simple delivery-based one. It permits cancellation for a refund before the doctor finalizes the prescription and the pharmacy starts processing; once processing starts, cancellation is unavailable. The documentation does not explain how customers are notified that this threshold has been crossed. Someone seeking to cancel should therefore ask for the order’s processing status rather than assume that an unshipped package remains cancellable.
The general rule is that orders are nonrefundable, but express exceptions matter. QueenRX promises a full refund if the initial telehealth visit finds the applicant ineligible, and the purchase block promises one if treatment is not prescribed. Approved refunds are processed within ten business days to the original payment method. Processing within that period is not a guarantee that the money will appear in the customer’s bank account by the same deadline.
For assistance, the refund policy lists support@joinqueenrx.com and live chat, with a two-day receipt-related reporting window. It does not provide a support-response guarantee. The general subscription terms separately refer to cancellation before a cutoff disclosed during purchase, without identifying this GLP-1 package as a subscription. Confirming the actual billing authorization, cancellation route and processing milestone would resolve more than relying on either the one-time-purchase banner or the general subscription clause alone.
Questions & answers
Can I currently place a new QueenRX order?
The consulted pages do not settle that question. An in-stock shipping statement appears alongside a new-order pause and a June 7 reopening date without a year. Ask support whether new applications and payments are currently accepted, and whether the advertised dispatch estimate applies to your selected package.
Does $299 buy three months of either medication?
That cannot be confirmed. The homepage associates $299 with quarterly compounded GLP-1 treatment without specifying the molecule. The product page places $699 and $299 under “First month” before the package selector. Obtain a package-specific total and exact covered period rather than assuming the same price applies to semaglutide and tirzepatide.
Is a prescription guaranteed after checkout?
No. The purchase description makes the prescription conditional on clinical appropriateness, and the advertised follow-up is conditional on eligibility. QueenRX promises a full refund if treatment is not prescribed; its refund policy also provides one for ineligibility determined during the initial telehealth visit. Payment should not be interpreted as clinical approval.
Can I use my own pharmacy?
The terms permit a pharmacy of your choice when that option is presented during the service process. They also offer partner-pharmacy fulfillment. This does not establish unrestricted outside-pharmacy access for every package or explain how an outside fill affects the advertised bundle price. Confirm both the transfer option and financial consequences before payment.
What should I do about a warm delivery or damaged package?
FDA advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. QueenRX separately asks for damage or dispensing-error reports within 48 hours, with order and tracking details and photographs when applicable. Its support email is support@joinqueenrx.com; live chat is another listed route.
Will QueenRX automatically renew my package?
The package advertises a one-time purchase without subscription or membership fees. General terms describe recurring charges for certain subscription services, but do not identify this package as one. Confirm the checkout authorization and what happens after the initial supply. Neither package duration nor general subscription language alone establishes a recurring commitment.
Our assessment
QueenRX documents a recognizable care pathway: an online intake, conditional prescribing through an affiliated practice, compounded medication supplied through pharmacy arrangements and advertised ongoing access. Its named operator, provider group, pharmacy listing and explicit early-refund exceptions give prospective patients useful points of reference. The weaker links are operational clarity. Conflicting availability notices, unreconciled prices, unspecified follow-up timing and incomplete product and delivery details prevent a confident account of what a new customer would receive and when. Before payment, the most useful confirmations are current enrollment status, the exact package and total charge, the responsible clinician and pharmacy, the follow-up plan and the point at which cancellation ends. Those answers would make the service easier to evaluate; the public documentation alone does not supply them.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.